Coloplast A/S Website

Coloplast A/S

CPSE-COLO B

Income Statement
Sep '14
Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
LTM

Total Revenues

17,939

18,544

19,426

22,579

24,500

26,303

Total Revenues % Chg.

9.1%

3.4%

4.8%

16.2%

8.5%

8.1%

Cost of Goods Sold, Total

5,743

5,932

6,113

7,050

8,172

8,542

Gross Profit

12,196

12,612

13,313

15,529

16,328

17,761

Selling General & Admin Expenses, Total

5,963

6,079

6,247

7,802

8,633

9,676

Stock-Based Compensation

—

7

7

2

-2

-1

-1

R&D Expenses

692

708

755

866

872

925

Other Operating Expenses

-42

-29

-48

-56

-25

-40

Other Operating Expenses, Total

6,620

6,765

6,956

8,610

9,479

10,560

Operating Income

5,576

5,847

6,357

6,919

6,849

7,201

Interest Expense, Total

-6

-30

-25

-172

-638

-789

Interest And Investment Income

19

8

11

39

111

154

Net Interest Expenses

13

-22

-14

-133

-527

-635

Income (Loss) On Equity Invest.

—

—

—

—

—

—

—

Currency Exchange Gains (Loss)

2

-338

114

-134

-178

-64

Other Non Operating Income (Expenses)

-168

-32

-31

-66

-78

-62

EBT, Excl. Unusual Items

5,423

5,455

6,426

6,586

6,066

6,440

Restructuring Charges

—

—

—

-43

—

—

—

—

—

Merger & Related Restructuring Charges

—

—

—

—

—

—

—

—

-171

-118

-383

Gain (Loss) On Sale Of Assets

—

16

—

-4

-7

-3

-3

Insurance Settlements

—

—

—

—

—

—

—

—

—

—

Legal Settlements

—

—

-400

—

-200

-300

-200

—

Other Unusual Items

—

—

—

32

11

11

19

280

265

EBT, Incl. Unusual Items

5,028

5,466

6,233

6,127

6,025

6,319

Income Tax Expense

1,155

1,269

1,408

1,421

1,242

1,352

Earnings From Continuing Operations

3,873

4,197

4,825

4,706

4,783

4,967

Net Income

3,873

4,197

4,825

4,706

4,783

4,967

Net Income to Common Incl Extra Items

3,873

4,197

4,825

4,706

4,783

4,967

Net Income to Common Excl. Extra Items

3,873

4,197

4,825

4,706

4,783

4,967

Total Shares Outstanding

212.4

212.7

212.8

212.3

224.7

224.8

Weighted Avg. Shares Outstanding

212.3

212.6

212.8

212.5

215.4

224.6

Weighted Avg. Shares Outstanding Dil

213.1

213.3

213.2

212.8

215.5

224.9

EPS

18.2

19.7

22.7

22.1

22.2

22.1

EPS Diluted

18.2

19.7

22.6

22.1

22.2

22.1

EBITDA

6,194

6,450

6,897

7,544

7,568

8,083

Effective Tax Rate

23%

23.2%

22.6%

23.2%

20.6%

21.4%